We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Diabetes

Journal Scan / Consensus and Guidelines · April 06, 2017

Statins Are Underutilized in NAFLD/NASH

Metabolism - Clinical and Experimental

 

Additional Info

Metabolism - Clinical and Experimental
The Use of Statins Alone, or in Combination With Pioglitazone and Other Drugs, for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Related Cardiovascular Risk. An Expert Panel Statement
Metab. Clin. Exp. 2017 Jun 01;71(xx)17-32, VG Athyros, TK Alexandrides, H Bilianou

Further Reading